Maternus-Kliniken Aktiengesellschaft (ETR:MAK)
Germany · Delayed Price · Currency is EUR 0.9200
0.00 (0.00%)
Aug 26, 2026, 5:35 PM CET
ETR:MAK Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 19 | 21 | 29 | 60 | 35 | 102 | |
Market Cap Growth | -29.77% | -25.00% | -52.45% | 71.26% | -65.64% | 10.96% |
Enterprise Value | 133 | 21 | 154 | 194 | 179 | 256 |
Last Close Price | 0.92 | 1.02 | 1.36 | 2.86 | 1.67 | 4.86 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 37.35 | 37.35 | 37.35 | 37.35 | 37.35 |
PS Ratio | 0.16 | 0.18 | 0.25 | 0.59 | 0.33 | 0.92 |
PB Ratio | -0.24 | -0.27 | -0.44 | -1.15 | -0.93 | -4.78 |
P/FCF Ratio | 1.73 | 1.92 | 2.06 | - | 15.00 | 6.65 |
P/OCF Ratio | 1.38 | 1.53 | 1.89 | 23.76 | 8.09 | 5.91 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.12 | 0.18 | 1.35 | 1.90 | 1.68 | 2.30 |
EV/EBITDA Ratio | 28.48 | - | - | - | - | 60.22 |
EV/EBIT Ratio | - | - | - | - | - | 230.15 |
EV/FCF Ratio | 11.87 | 1.86 | 11.09 | - | 76.60 | 16.69 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | -1.47 | -1.47 | -1.65 | -2.16 | -3.14 | -5.79 |
Debt / EBITDA Ratio | 24.94 | 24.94 | 12.55 | 231.65 | 135.26 | 10.11 |
Debt / FCF Ratio | 10.40 | 10.40 | 7.75 | - | 50.48 | 8.06 |
Net Debt / Equity Ratio | -1.41 | -1.41 | -1.60 | -2.14 | -3.05 | -5.16 |
Net Debt / EBITDA Ratio | -107.77 | -107.77 | -134.21 | -18.39 | -16.48 | 25.89 |
Net Debt / FCF Ratio | 10.01 | 10.01 | 7.52 | -77.35 | 49.10 | 7.18 |
Asset Turnover | 0.82 | 0.82 | 0.78 | 0.67 | 0.67 | 0.65 |
Inventory Turnover | 234.96 | 234.96 | 184.45 | 161.08 | 152.48 | 158.65 |
Quick Ratio | 0.18 | 0.18 | 0.11 | 0.24 | 0.20 | 0.40 |
Current Ratio | 0.21 | 0.21 | 0.13 | 0.30 | 0.30 | 0.48 |
Return on Assets (ROA) | -1.80% | -1.80% | -1.70% | -3.76% | -3.98% | 0.40% |
Return on Invested Capital (ROIC) | -7.45% | -13.23% | -9.50% | -10.64% | -9.43% | 0.88% |
Return on Capital Employed (ROCE) | -7.50% | -7.50% | -56.60% | -12.00% | -10.50% | 0.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -71.80% | -64.76% | -46.13% | -23.77% | -40.20% | -2.51% |
FCF Yield | 57.86% | 52.19% | 48.59% | -2.40% | 6.67% | 15.05% |